4.7 Editorial Material

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

Journal

SCIENCE IMMUNOLOGY
Volume 5, Issue 47, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciimmunol.abc5367

Keywords

-

Categories

Funding

  1. Pfizer

Ask authors/readers for more resources

JAK kinase inhibitors are being investigated as a way of managing cytokine storm in patients with severe COVID-19.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available